Cardiovascular prevention model from Kenyan slums to migrants in the Netherlands

被引:6
|
作者
van de Vijver, Steven [1 ,2 ]
Oti, Samuel [1 ,2 ]
van Charante, Eric Moll [3 ]
Allender, Steven [4 ]
Foster, Charlie [5 ]
Lange, Joep [1 ]
Oldenburg, Brian [6 ]
Kyobutungi, Catherine [1 ]
Agyemang, Charles [7 ]
机构
[1] African Populat & Hlth Res Ctr, Nairobi, Kenya
[2] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Family Med, NL-1105 AZ Amsterdam, Netherlands
[4] Deakin Univ, Dept Publ Hlth, Melbourne, Vic, Australia
[5] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England
[6] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia
[7] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands
关键词
Reverse innovation; Hypertension; Prevention; Treatment; Slums; Kenya; African migrants; HYPERTENSION; DISEASE; NAIROBI; AFRICA; PREVALENCE; AWARENESS; GHANAIAN; OBESITY;
D O I
10.1186/s12992-015-0095-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cardiovascular diseases (CVD) are the main cause of morbidity and mortality worldwide. As prevention and treatment of CVD often requires active screening and lifelong follow up it is a challenge for health systems both in high-income and low and middle-income countries to deliver adequate care to those in need, with efficient use of resources. We developed a health service model for primary prevention of CVD suitable for implementation in the Nairobi slums, based on best practices from public health and the private sectors. The model consists of four key intervention elements focusing on increasing awareness, incentives for promoting access to screening and treatment, and improvement of long-term adherence to prescribed medications. More than 5,000 slum dwellers aged >= 35 years and above have been screened in the study resulting in more than 1000 diagnosed with hypertension and referred to the clinic. Some marginalized groups in high-income countries like African migrants in the Netherlands also have low rates of awareness, treatment and control of hypertension as the slum population in Nairobi. The parallel between both groups is that they have a combination of risky lifestyle, are prone to chronic diseases such as hypertension, have limited knowledge about hypertension and its complications, and a tendency to stay away from clinics partly due to cultural beliefs in alternative forms of treatment, and lack of trust in health providers. Based on these similarities it was suggested by several policymakers that the model from Nairobi can be applied to other vulnerable populations such as African migrants in high-income countries. The model can be contextualized to the local situation by adapting the key steps of the model to the local settings. The involvement and support of African communities' infrastructures and health care staff is crucial, and the most important enabler for successful implementation of the model in migrant communities in high-income countries. Once these stakeholders have expressed their interest, the impact of the adapted intervention can be measured through an implementation research approach including collection of costs from health care providers' perspective and health effects in the target population, similar to the study design for Nairobi.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Primary prevention of cardiovascular disease through population-wide motivational strategies: insights from using smartphones in stroke prevention
    Feigin, Valery L.
    Norrving, Bo
    Mensah, George A.
    BMJ GLOBAL HEALTH, 2017, 2 (02):
  • [32] Screening and Interventions for Cardiovascular Disease Prevention in the Limpopo Province, South Africa: Use of the Community Action Model
    Mphekgwana, Peter M.
    Monyeki, Kotsedi D.
    Mothiba, Tebogo M.
    Makgahlela, Mpsanyana
    Kgatla, Nancy
    Malema, Rambelani N.
    Sodi, Tholene
    METABOLITES, 2022, 12 (11)
  • [33] Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach
    van Dis, I.
    Geleijnse, J. M.
    Verschuren, W. M. M.
    Kromhout, D.
    NETHERLANDS HEART JOURNAL, 2012, 20 (7-8) : 320 - 325
  • [34] Model for Predicting Cardiovascular Disease: Insights from a Korean Cardiovascular Risk Model
    Park, Gyung-Min
    Kim, Young-Hak
    PULSE, 2015, 3 (02) : 153 - 157
  • [35] The year in cardiovascular medicine 2020: epidemiology and prevention (Reprinted from Eur Heart J, vol 42, pg 813-821, 2021)
    Estruch, Ramon
    Ruilope, Luis M.
    Cosentino, Francesco
    COR ET VASA, 2021, 63 : 52 - 61
  • [36] 'Migrants from over there' or 'racial minority here'? Sexual networks and prevention practices among sub-Saharan African migrants in France
    Marsicano, Elise
    Lydie, Nathalie
    Bajos, Nathalie
    CULTURE HEALTH & SEXUALITY, 2013, 15 (07) : 819 - 835
  • [37] Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study
    Borghi, Claudio
    Tubach, Florence
    De Backer, Guy
    Dallongeville, Jean
    Guallar, Eliseo
    Medina, Jesus
    Perk, Joep
    Roy, Carine
    Banegas, Jose R.
    Rodriguez-Artalejo, Fernando
    Halcox, Julian P.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 218 : 83 - 88
  • [38] Community pharmacists perception and role in the prevention and management of cardiovascular disease conditions: Evidence from Ghana
    Henneh, Amanda Henewaa
    Tabong, Philip Teg-Nefaah
    INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2022, 37 (05) : 2794 - 2808
  • [39] Prevention of Metabolic Syndrome from Atypical Antipsychotic Medications Applying Rogers' Diffusion of Innovations Model in Clinical Practice
    Parrinello, Michael C.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2012, 50 (12) : 36 - 44
  • [40] PRIMARY PREVENTION OF SUDDEN CARDIOVASCULAR DEATH IN HYPERTENSIVE PATIENTS - MORTALITY RESULTS FROM THE MAPHY STUDY
    OLSSON, G
    TUOMILEHTO, J
    BERGLUND, G
    ELMFELDT, D
    WARNOLD, I
    BARBER, H
    ELIASSON, K
    JASTRUP, B
    KARATZAS, N
    LEER, J
    MARCHETTA, F
    RAGNARSSON, J
    ROBITAILLE, NM
    VALKOVA, L
    WESSELING, H
    WIKSTRAND, J
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (02) : 151 - 158